Skip to content

A study to test the efficacy of the Mag-Flo inhaler tuition device

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16154048
Enrollment
30
Registered
2006-09-29
Start date
2005-06-14
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory: Asthma/COPD Respiratory Asthma/COPD

Interventions

Fyne-Dynamics will supply conventional Mag-Flo devices for patient use. They will also supply special research devices that tog how long the inhalation lasted with flows between 30 and 60 L/min once t

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All outpatients referred by their clinician for inhaler training by staff at the Lung Investigation Unit at the Queen Elizabeth Hospital will be invited to partake in the study. Patients with a clinical diagnosis either of asthma or chronic obstructive pulmonary disease can be entered.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Measurements: the Mag-Flo device will be used to record 5 inhalations. The total duration of the inhalation and the duration of inhalation in the optimum low range will be recorded. During this assessment of the subjects ability the green light will not be operative in order to check the technique with the subject blinded. The mean duration of the best (i.e. longest time of inhalation in the correct flow range) two attempts writ be analysed as well as the mean and standard deviation of all 5 attempts. Spirometry to record PD/I, FVC and REF wilt he performed by technicians blind to he subjects grouping and will be according to British Thoracic Society guidelines before and 20 minutes after inhaling their prescribed dose of inhaler drug. Patients will fill in a satisfaction questionnaire about their perception of the device and how they got on with their inhaler.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026